Centogene reports third quarter 2021 financial results

Second consecutive quarter of core business growth, phasing out covid-19 testing and restructuring organization for core rare disease business second consecutive quarter of core business growth, phasing out covid-19 testing and restructuring organization for core rare disease business
CNTG Ratings Summary
CNTG Quant Ranking